Dr. Ahmad El-Ouweini

Clinical Lecturer, Clinical Pharmacist and Preceptor

Education

• Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmacy Specialties – American Pharmacists Association (APhA), USA, 2020
• ASHP-Accredited PGY-1 Pharmacy Residency, Lebanese American University & LAU Medical Center-Rizk Hospital, Lebanon, 2019
• Pharm.D. (with Distinct Honors), Lebanese American University (LAU), Lebanon, 2019
• BSc.Pharm (with Distinct Honors), Lebanese American University (LAU), Lebanon, 2018
• Antimicrobial Stewardship Certificate Program for Pharmacists” – Society of Infectious Diseases Pharmacists, USA, 2013
• B.Pharm (with Honors), Arab International University (AIU), Syria, 2011

Research Interests

• Cardiovascular Pharmacotherapy
• Critical Care Pharmacotherapy
• Academic Pharmacy

Selected Publications

• Ayash, B., Alkhoujah, S., Abraham, N.,  El Ouweini, A.,  Mansour, S.,  Gillani, S.W.,  Hallit, R., Hallit, S.,  Malaeb, D.  Assessment of the efficacy and safety of favipiravir in patients with SARS-CoV-2 infection in United Arab Emirates: A single-center study. Pharmacy Practice 2024 Apr-Jun;22(2):2917.
• Ahmad, H.,  El Oweini, A.,  Hallit, S., &  Malaeb, D . ( 2024) . Assessment of COVID-19 impact on menstrual symptom variation among women in the United Arab Emirates.  International Journal of Environmental Health Research , 1–9. [ link ]
• Menon, V., Al Ouweini, A.,  Arun, S., Marozou, A., Makarevich, P., & Lisavets, A. (2023).  Enhancing medical education: Exploring the use of virtual reality in practical sessions. Society for Simulation in Healthcare. [ link ]
• Mansour, H., Ouweini, A.,Chahine, E. and Karaoui, L., 2021. Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination. American Journal of Health-System Pharmacy, 78(8), pp.674-683. Link:  https://academic.oup.com/ajhp/article-abstract/78/8/674/6134520?redirectedFrom=fulltext
• Musa, S., Yeat, T., Kamal, L., Tabana, Y., Ahmed, M., Ouweini, A.,Lim, V., Keong, L. and Sandai, D., 2017. Pleurotus sajor-cajucan be used to synthesize silver nanoparticles with antifungal activity againstCandida albicans. Journal of the Science of Food and Agriculture, 98(3), pp.1197-1207. Link:  https://onlinelibrary.wiley.com/doi/10.1002/jsfa.8573
• Sandai, D., Tabana, Y., Ouweini, A.,and Ayodeji, I., 2016. Resistance of Candida albicans Biofilms to Drugs and the Host Immune System. Jundishapur Journal of Microbiology, 9(11). Link:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240163/